Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
177M
-
Number of holders
-
167
-
Total 13F shares, excl. options
-
140M
-
Shares change
-
+2.76M
-
Total reported value, excl. options
-
$1.22B
-
Value change
-
+$26.5M
-
Put/Call ratio
-
1.5
-
Number of buys
-
74
-
Number of sells
-
-63
-
Price
-
$8.70
Significant Holders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) as of Q3 2024
189 filings reported holding OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share as of Q3 2024.
OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) has 167 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 140M shares
of 177M outstanding shares and own 79.12% of the company stock.
Largest 10 shareholders include Summer Road LLC (14.4M shares), VR Adviser, LLC (12.8M shares), Deep Track Capital, LP (12.7M shares), BlackRock, Inc. (11.4M shares), VANGUARD GROUP INC (8.38M shares), Avoro Capital Advisors LLC (8.06M shares), TCG Crossover Management, LLC (5.32M shares), Opaleye Management Inc. (5.03M shares), CITADEL ADVISORS LLC (4.26M shares), and ADAGE CAPITAL PARTNERS GP, L.L.C. (3.75M shares).
This table shows the top 167 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.